Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome

Febrile infection-related epilepsy syndrome (FIRES) characteristically affects previously healthy children, who experience a sudden and explosive onset of super-refractory status epilepticus preceded by febrile infection and accompanied by fulminant neurogenic inflammation. FIRES, however, can affec...

Full description

Bibliographic Details
Main Authors: Joon Won Kang, Sookyong Koh
Format: Article
Language:English
Published: Korean Child Neurology Society 2023-07-01
Series:Annals of Child Neurology
Subjects:
Online Access:http://www.annchildneurol.org/upload/pdf/acn-2023-00031.pdf
_version_ 1797692847521005568
author Joon Won Kang
Sookyong Koh
author_facet Joon Won Kang
Sookyong Koh
author_sort Joon Won Kang
collection DOAJ
description Febrile infection-related epilepsy syndrome (FIRES) characteristically affects previously healthy children, who experience a sudden and explosive onset of super-refractory status epilepticus preceded by febrile infection and accompanied by fulminant neurogenic inflammation. FIRES, however, can affect individuals of all ages and is a subcategory of new-onset refractory status epilepticus. This definition of FIRES excludes febrile status epilepticus in infants. FIRES is a rare type of epileptic encephalopathy with rapidly progressive onset of seizures and a devastating prognosis, as drug-resistant epilepsy often follows without a latency period. Although the exact pathogenesis of FIRES has not been elucidated, a functional deficiency in the endogenous interleukin-1 receptor antagonist has been implicated in a genetic predisposition to FIRES. Dysregulation of the interleukin-1β–interleukin-1 receptor 1 (IL-1β–IL-1R1) signaling pathway appears to be involved in the pathogenesis of FIRES. In this review, the authors summarize the definition of FIRES, IL-1β–IL-1R1 signaling, the nucleotide-binding oligomerization domain the NLRP3 inflammasome, and IL-1 targeted therapy for FIRES.
first_indexed 2024-03-12T02:33:31Z
format Article
id doaj.art-1e8eafe92b5441398c33fc93afd58023
institution Directory Open Access Journal
issn 2635-909X
2635-9103
language English
last_indexed 2024-03-12T02:33:31Z
publishDate 2023-07-01
publisher Korean Child Neurology Society
record_format Article
series Annals of Child Neurology
spelling doaj.art-1e8eafe92b5441398c33fc93afd580232023-09-05T02:05:43ZengKorean Child Neurology SocietyAnnals of Child Neurology2635-909X2635-91032023-07-0131315116010.26815/acn.2023.000311325Interleukin-1 in Febrile Infection-Related Epilepsy SyndromeJoon Won Kang0Sookyong Koh1 Department of Pediatrics & Medical Science, Brain Research Institute, Chungnam National University College of Medicine, Daejeon, Korea Department of Pediatrics, Children’s Hospital & Medical Center, University of Nebraska, Omaha, NE, USAFebrile infection-related epilepsy syndrome (FIRES) characteristically affects previously healthy children, who experience a sudden and explosive onset of super-refractory status epilepticus preceded by febrile infection and accompanied by fulminant neurogenic inflammation. FIRES, however, can affect individuals of all ages and is a subcategory of new-onset refractory status epilepticus. This definition of FIRES excludes febrile status epilepticus in infants. FIRES is a rare type of epileptic encephalopathy with rapidly progressive onset of seizures and a devastating prognosis, as drug-resistant epilepsy often follows without a latency period. Although the exact pathogenesis of FIRES has not been elucidated, a functional deficiency in the endogenous interleukin-1 receptor antagonist has been implicated in a genetic predisposition to FIRES. Dysregulation of the interleukin-1β–interleukin-1 receptor 1 (IL-1β–IL-1R1) signaling pathway appears to be involved in the pathogenesis of FIRES. In this review, the authors summarize the definition of FIRES, IL-1β–IL-1R1 signaling, the nucleotide-binding oligomerization domain the NLRP3 inflammasome, and IL-1 targeted therapy for FIRES.http://www.annchildneurol.org/upload/pdf/acn-2023-00031.pdfdrug resistant epilepsyfeverinterleukin-1betainterleukin 1 receptor antagonist proteininflammasomes
spellingShingle Joon Won Kang
Sookyong Koh
Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome
Annals of Child Neurology
drug resistant epilepsy
fever
interleukin-1beta
interleukin 1 receptor antagonist protein
inflammasomes
title Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome
title_full Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome
title_fullStr Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome
title_full_unstemmed Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome
title_short Interleukin-1 in Febrile Infection-Related Epilepsy Syndrome
title_sort interleukin 1 in febrile infection related epilepsy syndrome
topic drug resistant epilepsy
fever
interleukin-1beta
interleukin 1 receptor antagonist protein
inflammasomes
url http://www.annchildneurol.org/upload/pdf/acn-2023-00031.pdf
work_keys_str_mv AT joonwonkang interleukin1infebrileinfectionrelatedepilepsysyndrome
AT sookyongkoh interleukin1infebrileinfectionrelatedepilepsysyndrome